Paget's disease of the breast

gan Karakas, Cansu
Cyhoeddwyd 2011

Molecular mechanisms involving prostate cancer racial disparity

gan Karakas, Cansu, Wang, Cassie, Deng, Fangming, Huang, Hongying, Wang, Dongwen, Lee, Peng
Cyhoeddwyd yn Am J Clin Exp Urol (2017)

Cyclin E associates with the lipogenic enzyme ATP-citrate lyase to enable malignant growth of breast cancer cells

gan Lucenay, Kimberly S., Doostan, Iman, Karakas, Cansu, Bui, Tuyen, Ding, Zhiyong, Mills, Gordon B., Hunt, Kelly K, Keyomarsi, Khandan
Cyhoeddwyd yn Cancer Res (2016)

PKC iota promotes ovarian tumor progression through deregulation of cyclin E

gan Nanos-Webb, Angela, Bui, Tuyen, Karakas, Cansu, Zhang, Dong, Carey, Jason P.W., Mills, Gordon B., Hunt, Kelly K., Keyomarsi, Khandan
Cyhoeddwyd yn Oncogene (2015)

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

gan Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K, Keyomarsi, Khandan
Cyhoeddwyd yn Breast Cancer Res (2014)

Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

gan Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K., Keyomarsi, Khandan
Cyhoeddwyd yn Breast Cancer Res (2015)

Cytoplasmic Cyclin E and Phospho–Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer

gan Karakas, Cansu, Biernacka, Anna, Bui, Tuyen, Sahin, Aysegul A., Yi, Min, Akli, Said, Schafer, Jolie, Alexander, Angela, Adjapong, Opoku, Hunt, Kelly K., Keyomarsi, Khandan
Cyhoeddwyd yn Am J Pathol (2016)

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer

gan Doostan, Iman, Karakas, Cansu, Kohansal, Mehrnoosh, Low, Kwang-Hui, Ellis, Matthew J., Olson, John A., Suman, Vera J., Hunt, Kelly K., Moulder, Stacy L., Keyomarsi, Khandan
Cyhoeddwyd yn Clin Cancer Res (2017)

Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple negative breast cancer

gan Carey, Jason. P.W., Karakas, Cansu, Bui, Tuyen, Chen, Xian, Vijayaraghavan, Smruthi, Zhao, Yang, Wang, Jing, Mikule, Keith, Litton, Jennifer K., Hunt, Kelly K., Keyomarsi, Khandan
Cyhoeddwyd yn Cancer Res (2017)

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age

gan Johnston, Simon J., Syed, Binafsha M., Parks, Ruth M., Monteiro, Cíntia J., Caruso, Joseph A., Green, Andrew R., Ellis, Ian O., Hunt, Kelly K., Karakas, Cansu, Keyomarsi, Khandan, Cheung, Kwok-Leung
Cyhoeddwyd yn Cancers (Basel) (2020)

LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers

gan Lulla, Amriti R., Akli, Said, Karakas, Cansu, Ha, Min Jin, Fowlkes, Natalie W., Mitani, Yoshitsugu, Bui, Tuyen, Wang, Jing, Rao, Xiayu, Hunt, Kelly K., Meijer, Laurent, El-Naggar, Adel K., Keyomarsi, Khandan
Cyhoeddwyd yn Oncogenesis (2021)

Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer

gan Karakas, Cansu, Francis, Ashleigh M., Ha, Min Jin, Wingate, Hannah F., Meena, Richard A., Yi, Min, Rasaputra, Komal S., Gutierrez Barrera, Angelica M., Arun, Banu, Do, Kim-Anh, Sahin, Aysegul, Keyomarsi, Khandan, Hunt, Kelly K.
Cyhoeddwyd yn Ann Surg (2021)

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer

gan Alexander, Angela, Karakas, Cansu, Chen, Xian, Carey, Jason P.W ., Yi, Min, Bondy, Melissa, Thompson, Patricia, Cheung, Kwok Leung, Ellis, Ian O., Gong, Yun, Krishnamurthy, Savitri, Alvarez, Ricardo H., Ueno, Naoto T., Hunt, Kelly K., Keyomarsi, Khandan
Cyhoeddwyd yn Oncotarget (2017)

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration

gan Chen, Xian, Yang, Dong, Carey, Jason P. W., Karakas, Cansu, Albarracin, Constance, Sahin, Aysegul A., Arun, Banu K., Guray Durak, Merih, Li, Mi, Kohansal, Mehrnoosh, Bui, Tuyen N., Ha, Min-Jin, Hunt, Kelly K., Keyomarsi, Khandan
Cyhoeddwyd yn Cancers (Basel) (2021)

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

gan Vijayaraghavan, Smruthi, Karakas, Cansu, Doostan, Iman, Chen, Xian, Bui, Tuyen, Yi, Min, Raghavendra, Akshara S., Zhao, Yang, Bashour, Sami I., Ibrahim, Nuhad K., Karuturi, Meghan, Wang, Jing, Winkler, Jeffrey D., Amaravadi, Ravi K., Hunt, Kelly K., Tripathy, Debu, Keyomarsi, Khandan
Cyhoeddwyd yn Nat Commun (2017)

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

gan Hunt, Kelly K., Karakas, Cansu, Ha, Min Jin, Biernacka, Anna, Yi, Min, Sahin, Aysegul A., Adjapong, Opoku, Hortobagyi, Gabriel N., Bondy, Melissa, Thompson, Patricia, Cheung, Kwok Leung, Ellis, Ian O., Bacus, Sarah, Symmans, W. Fraser, Do, Kim-Anh, Keyomarsi, Khandan
Cyhoeddwyd yn Clin Cancer Res (2016)

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition

gan Chen, Xian, Low, Kwang-Huei, Alexander, Angela, Jiang, Yufeng, Karakas, Cansu, Hess, Kenneth R., Carey, Jason P. W., Bui, Tuyen N., Vijayaraghavan, Smruthi, Evans, Kurt W., Yi, Min, Ellis, D. Christian, Cheung, Kwok-Leung, Ellis, Ian O., Fu, Siqing, Meric-Bernstam, Funda, Hunt, Kelly K., Keyomarsi, Khandan
Cyhoeddwyd yn Clin Cancer Res (2018)